Information on controls used in TruSight Oncology 500 demo datasets

Background

Illumina provides demo datasets for the TruSight Oncology 500 (TSO500) assay and analysis in the Demo Dataarrow-up-right section of BaseSpace to allow customers to understand expected outputs and results. Each demo dataset contains commercially available control samples, with some also including internally-derived test samples. In the tables below demo datasets are listed along with the controls used in each.

TSO500 (FFPE, solid assay)

TruSight Oncology 500; Commerical controls (DNA + RNA) on NextSeq 550Project:https://basespace.illumina.com/s/RfIEI4oB2ePiarrow-up-right

Sample ID

Sample Type

Vendor

Item

SeraCare0710_0097

DNA

SeraCare

Seraseq® Tri-Level Tumor Mutation DNA Mix v2

HorizonDx_HD827

DNA

HorizonDx

HD827: Mimix™ OncoSpan, gDNA Reference Standard

HorizonDx_HD753

DNA

HorizonDx

HD753: Mimix™ Structural Multiplex, FFPE Reference Standard

MilliporeSigma_87060101_1VL

DNA

MilliporeSigma

LoVo Cell Line human

ATCC_HCC_1395_CRL_2324D

DNA

ATCC

HCC1395 CRL-2324 ™

ATCC_A2058_CRL_11147D

DNA

ATCC

A2058 CRL-3601 ™

ATC_CCCL_225DQ

DNA

ATCC

HCT-15 Purified Genomic DNA, Quantitative (KRAS Mutant)

RNA_SeraCare_0710_0496

RNA

SeraCare

Seraseq® FFPE Tumor Fusion RNA v4 Reference Material

RNA_SeraCare_0710_1031

RNA

SeraCare

Seraseq® FFPE NTRK Fusion RNA Reference Material

RNA_SeraCare_0710_0137

RNA

SeraCare

Seraseq® FFPE WT (DNA/RNA) Reference Material

UHR_740000

RNA

Agilent

Universal Human Reference RNA

NovaSeq 6000Dx: TruSight Oncology 500 v2 Project: https://basespace.illumina.com/s/k5If7vXHZshIarrow-up-right

Sample ID

Sample Type

Vendor

Item

HD795_rep1_dna

DNA

HorizonDx

HD795: Mimix™ BRCA Somatic Multiplex I, FFPE Reference Standard

TSO500 ctDNA (liquid assay)

Control

Demo data

Seraseq® ctDNA Complete Mutation Mix

TruSight Oncology 500 ctDNA v2; SeraSeq ctDNA Complete Mutation Mix variants at 0.2% VAF on 1.5B flow cell Run: https://ilmn-tsotest.basespace.illumina.com/s/wS4hjl9WD1Pyarrow-up-right Project: https://ilmn-tsotest.basespace.illumina.com/s/RU9IFRUTOckRarrow-up-right TruSight Oncology 500 ctDNA v2; Cell line mixes samples on 10B flow cellRun: https://ilmn-tsotest.basespace.illumina.com/s/nwh4WgkNgpPgarrow-up-right Project: https://ilmn-tsotest.basespace.illumina.com/s/RU9IFRUTOckRarrow-up-right TruSight Oncology 500 ctDNA v2; 0.5% VAF SeraSeq ctDNA Complete Mutation Mix samples on 1.5B flow cell Run: https://ilmn-tsotest.basespace.illumina.com/s/WCK0QV7op8Jjarrow-up-rightProject: https://ilmn-tsotest.basespace.illumina.com/s/RU9IFRUTOckRarrow-up-right TruSight Oncology 500 ctDNA v2; 8 SeraSeq complete Mutation Mix samples on S2 flow cellRun: https://basespace.illumina.com/s/V506TtPbrkaDarrow-up-rightProject: https://basespace.illumina.com/s/H0O9C03OPbzgarrow-up-right NextSeq 2000 TruSight Oncology ctDNA 500 V2 with Seracare Controls at 0.5% VAF Project: https://basespace.illumina.com/s/Ppzn6tay3AO3arrow-up-right

SeraSeq® ctDNA Mutation Mix v2

TruSight Oncology 500 ctDNA v2; 4 SeraSeq Mutation Mix v2 samples on S2 flow cell Run: https://basespace.illumina.com/s/VWPmw2CfIR1Jarrow-up-rightProject: https://basespace.illumina.com/s/v0x6nsUx9H3larrow-up-right

For any feedback or questions regarding this article (Illumina Knowledge Article #10057), contact Illumina Technical Support [email protected]envelope.

Last updated

Was this helpful?